|Follow us :|
Luai Al Bakour
El Temamy Pharmacy
Akoni Hijyen Teknolojileri Sanayi ve Dış Ticaret LTD. ŞTİ
Britton Chance Center for Biomedical Photonics
Arabian Trade Center - ATC
Medical Facility (32206):
Legality International. (Pvt.) Ltd.
MainYou must sign in to use this servcie
Feedback - Please use the form below to send your query or comment
You must sign in to use this servcie
this medicine is for the control of vestibular disorders such as vertigo, tinnitus, nausea and vomiting such as is seen in Meniere’s Disease. this medicine is also effective in the control of motion sickness
this medicine should not be given to patients with known hypersensitivity to cinnarizine.
For all indications: Drowsiness and gastro-intestinal disturbances may occur. These are usually transient. In rare cases, headache, dry mouth, perspiration or allergic reactions may occur. For long term treatment, i.e. vestibular symptoms: Rare cases of weight gain and very rare cases of lichen planus, lupus-like skin reactions and cholestatic jaundice have been reported. Rare cases of aggravation or appearance of extrapyramidal symptoms (sometimes associated with depressive feelings) have been described, predominantly in elderly people during prolonged therapy. The treatment should be discontinued in such cases
Concurrent use of alcohol, CNS depressants or tricyclic antidepressants may potentiate the sedative effects of either these drugs or of this medicine.
As with other antihistamines, this medicine may cause epigastric discomfort; taking it after meals may diminish the gastric irritation. In patients with Parkinson’s Disease, this medicine should only be given if the advantages outweigh the possible risk of aggravating this disease. Because of its antihistamine effect, this medicine may prevent an otherwise positive reaction to dermal reactivity indicators if used within 4 days prior to testing. Use of cinnarizine should be avoided in porphyria. There have been no specific studies in hepatic or renal dysfunction. this medicine should be used with care in patients with hepatic or renal insufficiency. Patients with rare hereditary problems of fructose or galactose intolerance, Lapp lactase deficiency, glucose-galactose malabsorption or sucrase-isomaltase insufficiency, should not take this medicine because it contains lactose andh
SOLUTION FOR INJECTION
Dosage and AdministrationYou must sign in to use this servcie
Technical DescriptionYou must sign in to use this servcie
Dr. Faisal Dibsi
Dr. Tahsin Martini
Samir Moussa M.D.
Dr. Talal Sabouni
Dr. Hani Najjar
Yaser Habrawi , F.R.C.S.Ed
Dr. Samer Al-Jneidy
Dr . Dirar Abboud